Technology
Docusign Announces Third Quarter Fiscal 2025 Financial Results
Published
2 years agoon
By
SAN FRANCISCO , Dec. 5, 2024 /PRNewswire/ — Docusign, Inc. (NASDAQ: DOCU) today announced results for its fiscal quarter ended October 31, 2024. Prepared remarks and the news release with the financial results will be accessible on Docusign’s website at investor.docusign.com prior to its webcast.
“Docusign delivered powerful new innovation for customers highlighted by new capabilities to its Intelligent Agreement Management (“IAM”) platform,” said Allan Thygesen, CEO of Docusign. “In Q3, early IAM momentum outpaced expectations, and we continued to drive improvement in our core business with strong revenue growth and operating profit.”
Third Quarter Financial Highlights
Total revenue was $754.8 million, an 8% year-over-year increase. Subscription revenue was $734.7 million, an 8% year-over-year increase. Professional services and other revenue was $20.1 million, an 11% year-over-year increase.
Billings were $752.3 million, a 9% year-over-year increase.
GAAP gross margin was 79.3% compared to 79.6% in the same period last year. Non-GAAP gross margin was 82.5% compared to 83.0% in the same period last year.
GAAP net income per basic share was $0.31 on 204 million shares outstanding compared to $0.19 on 204 million shares outstanding in the same period last year.
GAAP net income per diluted share was $0.30 on 209 million shares outstanding compared to $0.19 on 208 million shares outstanding in the same period last year.
Non-GAAP net income per diluted share was $0.90 on 209 million shares outstanding compared to $0.79 on 208 million shares outstanding in the same period last year.
Net cash provided by operating activities was $234.3 million compared to $264.2 million in the same period last year.
Free cash flow was $210.7 million compared to $240.3 million in the same period last year.
Cash, cash equivalents, restricted cash and investments were $1.1 billion at the end of the quarter.
Repurchases of common stock were $172.7 million compared to $75.0 million in the same period last year.
A reconciliation of GAAP to non-GAAP financial measures has been provided in the tables included in this press release. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures and Other Key Metrics.”
Key Business Highlights:
IAM Product Releases and Highlights: Docusign announced new product capabilities to its IAM platform. Highlights from recent product releases include:
Docusign Navigator: Lexion’s AI capabilities were released to the IAM platform, including the ability to surface insights from a more extensive array of agreement types. Additionally, Navigator now includes the ability to import documents from third-party partners including Box, Dropbox, Google Drive, and Microsoft OneDrive. Also, Navigator now has an upgraded search experience that includes predictive type-ahead functionality, more filters, and the ability to export results.
Docusign IAM with Maestro and App Center Global Expansion: IAM with Docusign Maestro and IAM App Center availability expanded globally in the third fiscal quarter after the initial launch in the US, Canada, and Australia in May.
Contract Lifecycle Management (“CLM”) Product Releases and Highlights:
Docusign CLM Connector for SAP Ariba: Docusign Connector for SAP Ariba automates workflows to help businesses accelerate time to value and eliminate friction in source-to-pay agreement processes.
AI-assisted Contract Review for CLM: Incorporating Lexion’s AI technology, AI-assisted review was launched with availability for Microsoft Word allowing for AI-generated markups, language recommendations, and generative Q&A.
2024 Gartner Magic Quadrant Leader: For the fifth year in a row, Docusign was named a Leader in the 2024 Magic Quadrant for Contract Life Cycle Manager report by Gartner, Inc.
Developer Ecosystem:
Docusign Discover 2024: On November 20, Docusign held its first-ever agreement management ecosystem event, connecting customers, partners, and developers. Discover showcased Docusign IAM integrations with Microsoft, SAP, and Workday, and provided workshops and a virtual hackathon for developers to build across the entire agreement lifecycle. Docusign for Developers was also introduced as a suite of developer tools that partners will use to build apps powered by the IAM platform.
Copilot for Microsoft 365 Integration: Integration with Microsoft 365 allows agreements to be searchable by Copilot, the AI-powered chatbot available to Microsoft customers. Users across HR, Sales, Procurement, Legal, and more can use the Copilot for M365 integration to ask Copilot for outstanding agreements or agreement status using AI-powered chat experiences.
Guidance
The company currently expects the following guidance:
Quarter ending January 31, 2025 (in millions, except percentages):
Total revenue
$758
to
$762
Subscription revenue
$741
to
$745
Billings
$870
to
$880
Non-GAAP gross margin
81.0 %
to
82.0 %
Non-GAAP operating margin
27.5 %
to
28.5 %
Non-GAAP diluted weighted-average shares outstanding
209
to
214
Fiscal Year ending January 31, 2025 (in millions, except percentages):
Total revenue
$2,959
to
$2,963
Subscription revenue
$2,885
to
$2,889
Billings
$3,056
to
$3,066
Non-GAAP gross margin
81.9 %
to
82.1 %
Non-GAAP operating margin
29.5 %
to
29.7 %
Non-GAAP diluted weighted-average shares outstanding
210
to
212
A reconciliation of non-GAAP guidance measures to corresponding GAAP guidance measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty regarding, and the potential variability of, expenses that may be incurred in the future. Stock-based compensation-related charges, including employer payroll tax-related items on employee stock transactions, are impacted by many factors, including the timing of employee stock transactions, the future fair market value of our common stock, and our future hiring and retention needs, all of which are difficult to predict and subject to constant change. We have provided a reconciliation of GAAP to non-GAAP financial measures in the financial statement tables for our historical non-GAAP financial results included in this release.
Webcast Conference Call Information
The company will host a conference call on December 5, 2024 at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. A live webcast of the event will be available on the Docusign Investor Relations website at investor.docusign.com. Prepared remarks and the news release with the financial results will also be accessible on Docusign’s website prior to the webcast. A live dial-in will be available domestically at 877-407-0784 or internationally at 201-689-8560. A replay will be available domestically at 844-512-2921 or internationally at 412-317-6671 until midnight (EST) December 19, 2024 using the passcode 13750095.
About Docusign
Docusign brings agreements to life. Over 1.6 million customers and more than a billion people in over 180 countries use Docusign solutions to accelerate the process of doing business and simplify people’s lives. With intelligent agreement management, Docusign unleashes business critical data that is trapped inside of documents. Until now, these were disconnected from business systems of record, costing businesses time, money, and opportunity. Using Docusign’s IAM platform, companies can create, commit, and manage agreements with solutions created by the #1 company in e-signature and CLM. Learn more at www.docusign.com.
Copyright 2024. Docusign, Inc. is the owner of DOCUSIGN® and all its other marks (www.docusign.com/IP).
Investor Relations:
Docusign Investor Relations
investors@docusign.com
Media Relations:
Docusign Corporate Communications
media@docusign.com
Forward-Looking Statements
This press release contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on our management’s beliefs and assumptions and on information currently available to management, and which statements involve substantial risk and uncertainties. All statements contained in this press release other than statements of historical fact, including statements regarding our future operating results and financial position, our business strategy and plans, market growth and trends, objectives for future operations, and the impact of such assumptions on our financial condition and results of operations are forward-looking statements. Forward-looking statements in this press release also include, among other things, statements under “Guidance” above and any other statements about expected financial metrics, such as revenue, billings, non-GAAP gross margin, non-GAAP operating margin, non-GAAP diluted weighted-average shares outstanding, and non-financial metrics, as well as statements related to our expectations regarding the benefits, rollout and customer demand of the Docusign IAM platform. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions.
Forward-looking statements contained in this press release include, but are not limited to, statements about: our expectations regarding global macro-economic conditions, including the effects of inflation, volatile interest rates, and market volatility on the global economy; our ability to estimate the size and growth of our total addressable market; our ability to compete effectively in an evolving and competitive market; the impact of any data breaches, cyberattacks or other malicious activity on our technology systems; our ability to effectively sustain and manage our growth and future expenses and maintain or increase future profitability; our ability to attract new customers and maintain and expand our existing customer base; our ability to effectively implement and execute our restructuring plans; our ability to scale and update our platform to respond to customers’ needs and rapid technological change, including our ability to successfully incorporate generative artificial intelligence into our existing and future products; our ability to successfully execute our technical developments, go-to-market and sales strategy for our IAM platform; our ability to expand use cases within existing customers and vertical solutions; our ability to expand our operations and increase adoption of our platform internationally; our ability to strengthen and foster our relationships with developers; our ability to retain our direct sales force, customer success team and strategic partnerships around the world; our ability to identify targets for and execute potential acquisitions and to successfully integrate and realize the anticipated benefits of such acquisitions; our ability to maintain, protect and enhance our brand; the sufficiency of our cash, cash equivalents and capital resources to satisfy our liquidity needs; limitations on us due to obligations we have under our credit facility or other indebtedness; our ability to realize the anticipated benefits of our stock repurchase program; our failure or the failure of our software to comply with applicable industry standards, laws and regulations; our ability to maintain, protect and enhance our intellectual property; our ability to successfully defend litigation against us; our ability to attract large organizations as users; our ability to maintain our corporate culture; our ability to offer high-quality customer support; our ability to hire, retain and motivate qualified personnel, including executive level management; our ability to successfully manage and integrate executive management transitions; uncertainties regarding the impact of general economic and market conditions, including as a result of regional and global conflicts; and our ability to maintain proper and effective internal controls.
Additional risks and uncertainties that could affect our financial results are included in the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K for the fiscal year ended January 31, 2024 filed on March 21, 2024, our quarterly report on Form 10-Q for the quarter ended October 31, 2024, which we expect to file on December 6, 2024 with the Securities and Exchange Commission (the “SEC”), and other filings that we make from time to time with the SEC. The forward-looking statements made in this press release relate only to events as of the date on which such statements are made. We undertake no obligation to update any forward-looking statements after the date of this press release or to conform such statements to actual results or revised expectations, except as required by law.
Non-GAAP Financial Measures and Other Key Metrics
To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we use certain non-GAAP financial measures, as described below, to understand and evaluate our core operating performance. These non-GAAP financial measures, which may be different than similarly-titled measures used by other companies, are presented to enhance investors’ overall understanding of our financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.
We believe that these non-GAAP financial measures provide useful information about our financial performance, enhance the overall understanding of our past performance and future prospects, and allow for greater transparency with respect to important metrics used by our management for financial and operational decision-making. We present these non-GAAP measures to assist investors in seeing our financial performance using a management view, and because we believe that these measures provide an additional tool for investors to use in comparing our core financial performance over multiple periods with other companies in our industry. However, these non-GAAP measures are not intended to be considered in isolation from, a substitute for, or superior to our GAAP results.
Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP income from operations, non-GAAP operating margin, non-GAAP net income and non-GAAP net income per share: We define these non-GAAP financial measures as the respective GAAP measures, excluding expenses related to stock-based compensation, employer payroll tax on employee stock transactions, amortization of acquisition-related intangibles, amortization of debt discount and issuance costs, fair value adjustments to strategic investments, acquisition-related expenses, lease-related impairment and lease-related charges, restructuring and other related charges, as these costs are not reflective of ongoing operations and, as applicable, other special items. The amount of employer payroll tax-related items on employee stock transactions is dependent on our stock price and other factors that are beyond our control and do not correlate to the operation of the business. When evaluating the performance of our business and making operating plans, we do not consider these items (for example, when considering the impact of equity award grants, we place a greater emphasis on overall stockholder dilution rather than the accounting charges associated with such grants). We believe it is useful to exclude these expenses in order to better understand the long-term performance of our core business and to facilitate comparison of our results to those of peer companies and over multiple periods. In addition to these exclusions, we subtract an assumed provision for income taxes to calculate non-GAAP net income. We utilize a fixed long-term projected tax rate in our computation of the non-GAAP income tax provision to provide better consistency across the reporting periods. For fiscal 2024 and fiscal 2025, we have determined the projected non-GAAP tax rate to be 20%.
Free cash flow: We define free cash flow as net cash provided by operating activities less purchases of property and equipment. We believe free cash flow is an important liquidity measure of the cash that is available (if any), after purchases of property and equipment, for operational expenses, investment in our business, and to make acquisitions. Free cash flow is useful to investors as a liquidity measure because it measures our ability to generate or use cash in excess of our capital investments in property and equipment. Once our business needs and obligations are met, cash can be used to maintain a strong balance sheet and invest in future growth.
Billings: We define billings as total revenues plus the change in our contract liabilities and refund liability less contract assets and unbilled accounts receivable in a given period. Billings reflects sales to new customers plus subscription renewals and additional sales to existing customers. Only amounts invoiced to a customer in a given period are included in billings. We believe billings can be used to measure our periodic performance, when taking into consideration the timing aspects of customer renewals, which represents a large component of our business. Given that most of our customers pay in annual installments one year in advance, but we typically recognize a majority of the related revenue ratably over time, we use billings to measure and monitor our ability to provide our business with the working capital generated by upfront payments from our customers.
For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measure, please see “Reconciliation of GAAP to Non-GAAP Financial Measures” below.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended October 31,
Nine Months Ended October 31,
(in thousands, except per share data)
2024
2023
2024
2023
Revenue:
Subscription
$ 734,693
$ 682,352
$ 2,143,542
$ 1,991,026
Professional services and other
20,127
18,069
56,945
58,470
Total revenue
754,820
700,421
2,200,487
2,049,496
Cost of revenue:
Subscription
134,587
114,227
393,561
339,354
Professional services and other
21,950
28,418
67,887
85,360
Total cost of revenue
156,537
142,645
461,448
424,714
Gross profit
598,283
557,776
1,739,039
1,624,782
Operating expenses:
Sales and marketing
290,597
292,473
859,705
867,916
Research and development
151,101
136,640
432,992
387,964
General and administrative
97,555
108,215
277,162
316,910
Restructuring and other related charges
—
710
29,721
30,293
Total operating expenses
539,253
538,038
1,599,580
1,603,083
Income from operations
59,030
19,738
139,459
21,699
Interest expense
(462)
(1,577)
(1,150)
(5,135)
Interest income and other income, net
13,006
17,673
41,745
47,373
Income before provision for (benefit from) income taxes
71,574
35,834
180,054
63,937
Provision for (benefit from) income taxes
9,151
(2,971)
(804,340)
17,198
Net income
$ 62,423
$ 38,805
$ 984,394
$ 46,739
Net income per share attributable to common stockholders:
Basic
$ 0.31
$ 0.19
$ 4.81
$ 0.23
Diluted
$ 0.30
$ 0.19
$ 4.69
$ 0.23
Weighted-average shares used in computing net income per share:
Basic
203,567
204,456
204,674
203,609
Diluted
208,706
208,054
209,755
208,317
Stock-based compensation expense included in costs and expenses:
Cost of revenue—subscription
$ 14,862
$ 13,705
$ 44,636
$ 38,143
Cost of revenue—professional services and other
4,765
7,343
14,465
21,359
Sales and marketing
49,347
53,715
154,396
150,604
Research and development
53,184
48,310
150,816
129,458
General and administrative
31,070
36,337
91,239
111,271
Restructuring and other related charges
—
8
4,836
4,996
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands)
October 31, 2024
January 31, 2024
Assets
Current assets
Cash and cash equivalents
$ 610,870
$ 797,060
Investments—current
331,506
248,402
Accounts receivable, net
300,444
439,299
Contract assets—current
13,645
15,922
Prepaid expenses and other current assets
75,412
66,984
Total current assets
1,331,877
1,567,667
Investments—noncurrent
112,805
121,977
Property and equipment, net
278,623
245,173
Operating lease right-of-use assets
113,365
123,188
Goodwill
455,678
353,138
Intangible assets, net
83,307
50,905
Deferred contract acquisition costs—noncurrent
445,987
409,627
Deferred tax assets—noncurrent
816,538
2,031
Other assets—noncurrent
132,028
97,584
Total assets
$ 3,770,208
$ 2,971,290
Liabilities and Equity
Current liabilities
Accounts payable
$ 18,144
$ 19,029
Accrued expenses and other current liabilities
94,591
104,037
Accrued compensation
158,779
195,266
Contract liabilities—current
1,307,749
1,320,059
Operating lease liabilities—current
19,507
22,230
Total current liabilities
1,598,770
1,660,621
Contract liabilities—noncurrent
22,931
21,980
Operating lease liabilities—noncurrent
111,132
120,823
Deferred tax liability—noncurrent
19,303
16,795
Other liabilities—noncurrent
28,695
21,332
Total liabilities
1,780,831
1,841,551
Stockholders’ equity
Common stock
20
21
Treasury stock
(2,871)
(2,164)
Additional paid-in capital
3,225,481
2,821,461
Accumulated other comprehensive loss
(23,682)
(19,360)
Accumulated deficit
(1,209,571)
(1,670,219)
Total stockholders’ equity
1,989,377
1,129,739
Total liabilities and equity
$ 3,770,208
$ 2,971,290
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended
October 31,
Nine Months Ended
October 31,
(in thousands)
2024
2023
2024
2023
Cash flows from operating activities:
Net income
$ 62,423
$ 38,805
$ 984,394
$ 46,739
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
27,569
23,324
79,097
71,429
Amortization of deferred contract acquisition and fulfillment costs
61,264
49,399
172,731
147,781
Amortization of debt discount and transaction costs
138
1,227
415
3,722
Non-cash operating lease costs
4,601
4,768
14,463
16,499
Stock-based compensation expense
153,228
159,418
460,388
455,831
Deferred income taxes
6,675
3,845
(817,886)
7,265
Other
1,149
(571)
6,472
(1,353)
Changes in operating assets and liabilities:
Accounts receivable
7,120
53,099
130,691
152,902
Prepaid expenses and other current assets
8,767
6,463
(8,300)
(7,957)
Deferred contract acquisition and fulfillment costs
(83,293)
(63,154)
(214,548)
(176,510)
Other assets
(1,060)
(5,586)
(16,118)
(14,019)
Accounts payable
10,061
11,205
(1,514)
(9,089)
Accrued expenses and other liabilities
1,014
(7,792)
(7,146)
2,372
Accrued compensation
(21,226)
(1,056)
(41,128)
(4,368)
Contract liabilities
95
(3,582)
(16,431)
36,876
Operating lease liabilities
(4,199)
(5,635)
(16,220)
(19,292)
Net cash provided by operating activities
234,326
264,177
709,360
708,828
Cash flows from investing activities:
Cash paid for acquisition, net of acquired cash
—
—
(143,611)
—
Purchases of marketable securities
(110,296)
(28,974)
(333,537)
(203,346)
Maturities of marketable securities
90,211
87,500
265,834
251,517
Purchases of strategic and other investments
—
(400)
(625)
(520)
Purchases of property and equipment
(23,613)
(23,841)
(68,646)
(70,277)
Net cash provided by (used in) investing activities
(43,698)
34,285
(280,585)
(22,626)
Cash flows from financing activities:
Repayments of convertible senior notes
—
(37,083)
—
(37,083)
Repurchases of common stock
(172,665)
(75,035)
(521,803)
(145,515)
Settlement of capped calls, net of related costs
—
—
—
23,688
Payment of tax withholding obligation on net RSU settlement and ESPP purchase
(51,051)
(35,615)
(132,134)
(98,296)
Proceeds from exercise of stock options
10,257
12,375
11,346
13,207
Proceeds from employee stock purchase plan
15,124
14,604
35,314
32,994
Net cash used in financing activities
(198,335)
(120,754)
(607,277)
(211,005)
Effect of foreign exchange on cash, cash equivalents and restricted cash
438
(7,187)
(2,239)
(4,897)
Net increase (decrease) in cash, cash equivalents and restricted cash
(7,269)
170,521
(180,741)
470,300
Cash, cash equivalents and restricted cash at beginning of period (1)
628,027
1,022,980
801,499
723,201
Cash, cash equivalents and restricted cash at end of period (1)
$ 620,758
$ 1,193,501
$ 620,758
$ 1,193,501
(1) Cash, cash equivalents and restricted cash included restricted cash of $9.9 million and $4.4 million at October 31, 2024 and January 31, 2024.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(Unaudited)
Reconciliation of gross profit (loss) and gross margin:
Three Months Ended
October 31,
Nine Months Ended
October 31,
(in thousands)
2024
2023
2024
2023
GAAP gross profit
$ 598,283
$ 557,776
$ 1,739,039
$ 1,624,782
Add: Stock-based compensation
19,627
21,048
59,101
59,502
Add: Amortization of acquisition-related intangibles
3,566
2,070
8,703
6,787
Add: Employer payroll tax on employee stock transactions
894
537
2,733
1,925
Add: Lease-related impairment and lease-related charges
—
—
—
721
Non-GAAP gross profit
$ 622,370
$ 581,431
$ 1,809,576
$ 1,693,717
GAAP gross margin
79.3 %
79.6 %
79.0 %
79.3 %
Non-GAAP adjustments
3.2 %
3.4 %
3.2 %
3.3 %
Non-GAAP gross margin
82.5 %
83.0 %
82.2 %
82.6 %
GAAP subscription gross profit
$ 600,106
$ 568,125
$ 1,749,981
$ 1,651,672
Add: Stock-based compensation
14,862
13,705
44,636
38,143
Add: Amortization of acquisition-related intangibles
3,566
2,070
8,703
6,787
Add: Employer payroll tax on employee stock transactions
574
301
1,961
1,232
Add: Lease-related impairment and lease-related charges
—
—
—
505
Non-GAAP subscription gross profit
$ 619,108
$ 584,201
$ 1,805,281
$ 1,698,339
GAAP subscription gross margin
81.7 %
83.3 %
81.6 %
83.0 %
Non-GAAP adjustments
2.6 %
2.3 %
2.6 %
2.3 %
Non-GAAP subscription gross margin
84.3 %
85.6 %
84.2 %
85.3 %
GAAP professional services and other gross loss
$ (1,823)
$ (10,349)
$ (10,942)
$ (26,890)
Add: Stock-based compensation
4,765
7,343
14,465
21,359
Add: Employer payroll tax on employee stock transactions
320
236
772
693
Add: Lease-related impairment and lease-related charges
—
—
—
216
Non-GAAP professional services and other gross profit
$ 3,262
$ (2,770)
$ 4,295
$ (4,622)
GAAP professional services and other gross margin
(9.1) %
(57.3) %
(19.2) %
(46.0) %
Non-GAAP adjustments
25.3 %
42.0 %
26.7 %
38.1 %
Non-GAAP professional services and other gross margin
16.2 %
(15.3) %
7.5 %
(7.9) %
Reconciliation of operating expenses:
Three Months Ended
October 31,
Nine Months Ended
October 31,
(in thousands)
2024
2023
2024
2023
GAAP sales and marketing
$ 290,597
$ 292,473
$ 859,705
$ 867,916
Less: Stock-based compensation
(49,347)
(53,715)
(154,396)
(150,604)
Less: Amortization of acquisition-related intangibles
(3,354)
(2,629)
(9,096)
(7,888)
Less: Employer payroll tax on employee stock transactions
(1,618)
(875)
(5,351)
(3,945)
Less: Lease-related impairment and lease-related charges
—
—
—
(2,171)
Non-GAAP sales and marketing
$ 236,278
$ 235,254
$ 690,862
$ 703,308
GAAP sales and marketing as a percentage of revenue
38.4 %
41.8 %
39.1 %
42.3 %
Non-GAAP sales and marketing as a percentage of revenue
31.3 %
33.6 %
31.4 %
34.3 %
GAAP research and development
$ 151,101
$ 136,640
$ 432,992
$ 387,964
Less: Stock-based compensation
(53,184)
(48,310)
(150,816)
(129,458)
Less: Employer payroll tax on employee stock transactions
(1,273)
(876)
(5,592)
(3,671)
Less: Lease-related impairment and lease-related charges
—
—
—
(873)
Non-GAAP research and development
$ 96,644
$ 87,454
$ 276,584
$ 253,962
GAAP research and development as a percentage of revenue
20.0 %
19.5 %
19.7 %
18.9 %
Non-GAAP research and development as a percentage of revenue
12.8 %
12.4 %
12.6 %
12.4 %
GAAP general and administrative
$ 97,555
$ 108,215
$ 277,162
$ 316,910
Less: Stock-based compensation
(31,070)
(36,337)
(91,239)
(111,271)
Less: Employer payroll tax on employee stock transactions
(489)
(564)
(1,774)
(1,541)
Less: Acquisition-related expenses
376
—
(4,340)
—
Less: Lease-related impairment and lease-related charges
—
—
—
(695)
Non-GAAP general and administrative
$ 66,372
$ 71,314
$ 179,809
$ 203,403
GAAP general and administrative as a percentage of revenue
12.9 %
15.4 %
12.6 %
15.4 %
Non-GAAP general and administrative as a percentage of revenue
8.8 %
10.2 %
8.1 %
9.9 %
Reconciliation of income from operations and operating margin:
Three Months Ended
October 31,
Nine Months Ended
October 31,
(in thousands)
2024
2023
2024
2023
GAAP income from operations
$ 59,030
$ 19,738
$ 139,459
$ 21,699
Add: Stock-based compensation
153,228
159,410
455,552
450,835
Add: Amortization of acquisition-related intangibles
6,920
4,699
17,799
14,675
Add: Employer payroll tax on employee stock transactions
4,274
2,852
15,450
11,082
Add: Acquisition-related expenses
(376)
—
4,340
—
Add: Restructuring and other related charges
—
710
29,721
30,293
Add: Lease-related impairment and lease-related charges
—
—
—
4,460
Non-GAAP income from operations
$ 223,076
$ 187,409
$ 662,321
$ 533,044
GAAP operating margin
7.8 %
2.8 %
6.3 %
1.1 %
Non-GAAP adjustments
21.8 %
24.0 %
23.8 %
24.9 %
Non-GAAP operating margin
29.6 %
26.8 %
30.1 %
26.0 %
Reconciliation of net income and net income per share, basic and diluted:
Three Months Ended
October 31,
Nine Months Ended
October 31,
(in thousands, except per share data)
2024
2023
2024
2023
GAAP net income
$ 62,423
$ 38,805
$ 984,394
$ 46,739
Add: Stock-based compensation
153,228
159,410
455,552
450,835
Add: Amortization of acquisition-related intangibles
6,920
4,699
17,799
14,675
Add: Employer payroll tax on employee stock transactions
4,274
2,852
15,450
11,082
Add: Acquisition-related expenses
(376)
—
4,340
—
Add: Restructuring and other related charges
—
710
29,721
30,293
Add: Amortization of debt discount and issuance costs
—
1,250
—
4,149
Add: Fair value adjustments to strategic investments
—
—
—
119
Add: Lease-related impairment and lease-related charges
—
—
—
4,460
Add: Income tax and other tax adjustments
(37,973)
(43,922)
(944,923)
(98,712)
Non-GAAP net income
$ 188,496
$ 163,804
$ 562,333
$ 463,640
Numerator:
Non-GAAP net income
$ 188,496
$ 163,804
$ 562,333
$ 463,640
Add: Interest expense on convertible senior notes
—
22
—
425
Non-GAAP net income attributable to common stockholders, diluted
$ 188,496
$ 163,826
$ 562,333
$ 464,065
Denominator:
Weighted-average common shares outstanding, basic
203,567
204,456
204,674
203,609
Effect of dilutive securities
5,139
3,598
5,081
4,708
Non-GAAP weighted-average common shares outstanding, diluted
208,706
208,054
209,755
208,317
GAAP net income per share, basic
$ 0.31
$ 0.19
$ 4.81
$ 0.23
GAAP net income per share, diluted
$ 0.30
$ 0.19
$ 4.69
$ 0.23
Non-GAAP net income per share, basic
$ 0.93
$ 0.80
$ 2.75
$ 2.28
Non-GAAP net income per share, diluted
$ 0.90
$ 0.79
$ 2.68
$ 2.23
Computation of free cash flow:
Three Months Ended
October 31,
Nine Months Ended
October 31,
(in thousands)
2024
2023
2024
2023
Net cash provided by operating activities
$ 234,326
$ 264,177
$ 709,360
$ 708,828
Less: Purchases of property and equipment
(23,613)
(23,841)
(68,646)
(70,277)
Non-GAAP free cash flow
$ 210,713
$ 240,336
$ 640,714
$ 638,551
Net cash provided by (used in) investing activities
$ (43,698)
$ 34,285
$ (280,585)
$ (22,626)
Net cash used in financing activities
$ (198,335)
$ (120,754)
$ (607,277)
$ (211,005)
Computation of billings:
Three Months Ended
October 31,
Nine Months Ended
October 31,
(in thousands)
2024
2023
2024
2023
Revenue
$ 754,820
$ 700,421
$ 2,200,487
$ 2,049,496
Add: Contract liabilities and refund liability, end of period
1,332,828
1,228,174
1,332,828
1,228,174
Less: Contract liabilities and refund liability, beginning of period
(1,334,461)
(1,233,894)
(1,343,792)
(1,191,269)
Add: Contract assets and unbilled accounts receivable, beginning of period
17,461
22,358
20,189
16,615
Less: Contract assets and unbilled accounts receivable, end of period
(18,341)
(25,253)
(18,341)
(25,253)
Add: Contract assets and unbilled accounts receivable by acquisitions
—
—
53
—
Less: Contract liabilities and refund liability contributed by acquisitions
—
—
(5,071)
—
Non-GAAP billings
$ 752,307
$ 691,806
$ 2,186,353
$ 2,077,763
View original content:https://www.prnewswire.com/news-releases/docusign-announces-third-quarter-fiscal-2025-financial-results-302324214.html
SOURCE Docusign, Inc.
You may like
Technology
Harlem Children’s Zone Acquires FinTech Platform, Goalsetter, to Accelerate Universal Economic Mobility
Published
5 minutes agoon
October 22, 2026By
Acquisition combines HCZ’s proven model with Goalsetter’s innovative financial education technology to expand access and impact at scale
NEW YORK, Oct. 22, 2026 /PRNewswire/ — Today, Harlem Children’s Zone (HCZ), one of the nation’s leading anti-poverty organizations, announced the acquisition of Goalsetter, a financial technology platform that delivers best-in-class, engaging, technology-enabled learning experiences for people seeking to enhance their financial know-how, capabilities, and confidence.
The acquisition marks a significant step in HCZ’s Wealth Builds–Universal Economic Mobility (WB-UEM) strategy, a national framework designed to help children and families build long-term economic security through cradle-to-career supports, financial education and experiences, and direct access to capital via a Child Capital Stack of asset boosts.
“We know that economic mobility is a two-generation challenge,” says Harlem Children’s Zone CEO Kwame Owusu-Kesse. “With this acquisition, we are solving for a critical component of Universal Economic Mobility by melding a proven financial education platform and HCZ’s decades of experience providing people with the knowledge and tools to build strong futures for themselves and their families. This is more than an investment in financial education. It is an investment in critical national infrastructure for economic mobility.”
Harlem Children’s Zone has decades of experience driving outcomes at scale, beginning as a one-block pilot, expanding to over 100 blocks in Central Harlem, and now working with over 70 communities across the United States. HCZ seeks to use its learnings, decades of experience driving outcomes at scale, and renowned best practices to provide pathways to economic mobility for all of America’s children and families.
“Goalsetter was built on the belief that everyone should have access to the financial knowledge and tools that can shape their future and livelihood,” said Tanya Van Court, Chief FinTech Officer at Harlem Children’s Zone and Founder of Goalsetter. “Joining Harlem Children’s Zone gives us an extraordinary opportunity to build on that work. Together, we can continue enhancing the platform, expand access for learners of all ages and walks of life, and demonstrate what is possible when mission, innovation, and technology come together to serve the most people.”
Goalsetter creates opportunities to deliver high-quality, developmentally appropriate and culturally relevant financial education with extensive reach, including to low-income and rural communities that have historically had limited access to these resources. Its current offerings include Goalsetter Classroom, which provides standards-aligned financial education curriculum for middle and high school students, and MoneyLingo, a mobile-first financial education experience for college-aged students and adults in the workforce, covering practical topics such as saving, investing, credit, debt, and financial decision-making.
“This acquisition sends an important signal to the field,” said Owusu-Kesse. “Social impact organizations should not have to choose between mission and scale. By bringing a proven technology platform into HCZ, we’re demonstrating how non-profit organizations can be centers of business excellence, using vehicles of innovation, AI, and technology to create efficient and effective pathways to scale and impact. This acquisition strengthens our in-house capacity to build, innovate, and continuously improve outcomes.”
The organization plans to build upon Goalsetter’s existing offerings by exploring financial education products for younger learners and creating opportunities to establish a continuous financial learning journey from early childhood through adulthood.
“This is ultimately about extending opportunity to all,” added Owusu-Kesse. “By connecting financial education, technology, family engagement, and access to assets, we can help create more accessible pathways to economic mobility.”
Services to current Goalsetter clients will be unaffected by this acquisition.
View original content:https://www.prnewswire.com/news-releases/harlem-childrens-zone-acquires-fintech-platform-goalsetter-to-accelerate-universal-economic-mobility-302917320.html
SOURCE Harlem Children’s Zone
Technology
Common Ground in the Battlegrounds? Surveys Reveal Widespread Bipartisan Agreement in 11 Competitive States and 28 Congressional Districts, as Well as Nationally
Published
5 minutes agoon
October 22, 2026By
Bipartisan Majorities Say If Congress Were to Listen to the People More, They Would More Likely Find Common Ground
COLLEGE PARK, Md., Oct. 22, 2026 /PRNewswire/ — The Program for Public Consultation (PPC) conducted extensive surveys in competitive states and congressional districts, as well as nationally, revealing a remarkable level of bipartisan common ground.
Majorities of both Democrats and Republicans agreed on:
106 policies nationally 82 policies in all states and districts surveyed101 policies in at least two-thirds of all the states and districts surveyed
Over 40,000 Americans were surveyed in two waves with representative samples of 600-2,016 in each of the 11 competitive states surveyed, and 400-592 in each of the 28 competitive congressional districts surveyed, and 1,200-2,509 nationwide.
Nearly all policy questions were based on congressional legislation or executive branch proposals.
Fourteen policy topics were covered: Artificial Intelligence, Housing, Healthcare, Low-Income Assistance, Families and Children, Social Security, Immigration, Abortion and Birth Control, Energy and Environment, Federal Taxes, Campaign Finance, Government Reform, Criminal Justice and America’s Role in the World. For every topic, most policies had bipartisan agreement across every battleground surveyed.
The policy questions used in these national and battleground surveys were chosen because they elicited bipartisan support in previous in-depth national surveys conducted by PPC, in which respondents received briefings on the topic and evaluated pro and con arguments for the proposed policy.
Steven Kull, director of PPC, comments, “What is striking here is that these surveys revealed widespread bipartisan agreement on over a dozen key issues that Congress has failed to resolve, from costs of healthcare, to risks of artificial intelligence, to Social Security’s impending insolvency, and many more. Clearly, there is far more common ground among the American people than there is in Congress.”
Americans Think Public Opinion Should Have More Influence
Respondents were also asked about the role of public opinion in policymaking. Across the battlegrounds, on average, respondents estimated that federally elected officials make the same decisions that the majority of Americans would make just 35% of the time.
Large majorities believe polarization in government comes not from the American people but from elected officials, and that more influence for the people would help break the logjam in Congress (Democrats 62 to 88%, Republicans 66 to 89%).
Perhaps most germane, overwhelming majorities of Democrats and Republicans in the battlegrounds believe that if members of Congress were more influenced by the people, they would be more likely to find common ground (Democrats 82 to 97%, Republicans 80 to 95%), and better serve the common good (Democrats 77 to 94%, Republicans 79 to 94%).
Steven Kull adds, “On the basis of this study, it does appear that the public is correct that if the people had more influence, Congress would be more likely to find common ground, and thus function better.”
Americans also say that public opinion should play a substantial role in news reporting about policy. Over two-thirds say news reports on policy matters should include public opinion data most of the time or always when reliable information is available (Democrats 71 to 88%, Republicans 67 to 89%). Similarly, when Congress is about to vote on a law, large numbers say it is very or extremely important for news outlets to report whether a majority of Americans favor or oppose it (Democrats 65 to 84%, Republicans 60 to 85%).
MORE INFORMATION
Battlegrounds Common Ground SheetIndividual State and District Results, Questionnaires and MethodologiesNational Questionnaire with Toplines, Crosstabs and Methodology
About the Surveys
The state and district surveys used for this analysis were fielded July 21 – August 17, 2026, to a total of 19,949 adults, and May 27 – July 1, 2026, to 19,564 adults. They included 600-2016 in each of the 11 states, and 400-592 in each of the 28 congressional districts. Response rates ranged from 7.1 to 9.0%. Confidence intervals range from +/- 2.9 to 8.1%, and maximum weights range from 1.9 to 10.0.
The national surveys were fielded February 11-26, 2026, with 2,509 adults, and March 11-19, 2026, with 1,200 adults. The response rates were 7.6% and 8.3%, respectively. The confidence interval is +/- 2.9% for both surveys, and the maximum weights are 2.5 and 1.9.
The sample was obtained from multiple online opt-in panels, including Cint, Dynata and Prodege. Sample collection and quality control were managed by QuantifyAI under the direction of the Program for Public Consultation. The surveys were offered in both English and Spanish.
The samples were pre-stratified and weighted by age, race, ethnicity, gender, education, household income, marital status, and home ownership to match the general adult population. The national sample was further weighted by Census region. The distribution of partisan affiliation was within expectations, based on voter registration data for non-leaners and/or Cook’s Partisan Voting Index for leaners, or weighted to reflect those benchmarks.
About the Common Ground in the Battlegrounds? Survey Series
This effort aims to identify bipartisan common ground in competitive states and districts across the nation. The project seeks to educate the public, policymakers and candidates about the findings; and provide journalists with independent, nonpartisan research that brings the public into the conversation about public policy.
In addition to PPC, project partners include the Civic Innovation Center at the University of Maryland (CivIC) and Voice of the People (VOP), a national nonpartisan organization seeking to give the public a greater voice in government. None of these entities advocate for policy positions or endorse candidates.
States surveyed: Alaska; Georgia; Iowa; Maine; Michigan; Minnesota; Montana; Nebraska; New Hampshire; North Carolina; Ohio; and Texas.
Congressional Districts surveyed: Arizona’s 1st and 6th; Colorado’s 8th; Iowa’s 1st, 2nd, 3rd and 4th; Maine’s 2nd; Michigan’s 4th, 7th, 8th and 10th; Montana’s 1st; Nebraska’s 2nd; Nevada’s 3rd; New Jersey’s 7th and 9th; New Mexico’s 2nd; New York’s 3rd, 4th, 17th and 19th; Oregon’s 5th; Pennsylvania’s 1st, 7th, 8th and 10th; and Washington’s 3rd.
The survey series excluded several competitive districts because they were in states that had recently been redistricted and thus had no Census data yet to use for demographic benchmarks.
Program for Public Consultation
The Program for Public Consultation (PPC), affiliated with the University of Maryland’s School of Public Policy, seeks to improve democratic governance by consulting the public and bringing the people’s views into the public discourse. It conducts surveys with representative samples on policies proposed by elected officials and shares its findings with government officials, the media, other academics, and the general public.
Civic Innovation Center
The Civic Innovation Center (CivIC) at the University of Maryland’s School of Public Policy works to strengthen the foundations of civic health. It contributes to important debates about civic education, civic engagement, and needed democratic reforms in the state of Maryland and nationwide, in partnership with other BIG 10 universities. It works to build the connective tissue that brings together students, scholars and practitioners to help elevate the UMD community’s contribution to our wider democracy.
Voice of the People
Voice of the People (VOP) is a nonpartisan organization working to re-anchor our democracy in its founding principles by giving ‘We the People’ a greater and more effective voice in government. It champions innovative methods and technology that enable the American people to play a role in the policymaking process and provide policymakers with a more accurate understanding of the views of their constituents.
Contact: Jonathan Casaverde, jonathan.casaverde@wardcirclestrategies.com,(786) 469-9422
View original content to download multimedia:https://www.prnewswire.com/news-releases/common-ground-in-the-battlegrounds-surveys-reveal-widespread-bipartisan-agreement-in-11-competitive-states-and-28-congressional-districts-as-well-as-nationally-302915872.html
SOURCE Program for Public Consultation
Technology
FDA grants 510(k) clearance for BoneEnhance, the first machine learning layer on RIVANNA’s Accuro XV platform
Published
5 minutes agoon
October 22, 2026By
Anatomy segmentation and three-dimensional skeletal visualization arrive with this clearance; an injury detection module for clinical decision support is in development on the platform roadmap
CHARLOTTESVILLE, Va., Oct. 22, 2026 /PRNewswire/ — RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for BoneEnhance®, a machine learning software module for the Accuro® XV diagnostic ultrasound system. The module segments bone and surrounding tissues and supports visualization of skeletal anatomy in three dimensions during image review.
The clearance moves the platform from acquisition toward interpretation. Accuro XV was cleared in April 2026 for B-mode imaging in musculoskeletal conventional and superficial applications. Its conformable three-dimensional probe automates large field-of-view image acquisition after initial patient positioning. BoneEnhance is the first machine learning software module cleared for the platform.
BoneEnhance identifies bone and surrounding tissues
Each automated acquisition creates a volumetric dataset for review. BoneEnhance identifies bone and surrounding tissues within that volume, then highlights them with color-coded overlays on the two-dimensional B-mode image. The original anatomical data remain unaltered and visible beneath the overlays. A three-dimensional indicator beside the image shows the scan orientation and the location of the displayed slice within the volume.
A platform milestone
The sequence is deliberate: decision support begins at acquisition. Accuro XV acquires the image; BoneEnhance identifies and labels the anatomy within it. Behind the integrated workflow stands a worldwide intellectual-property portfolio of more than 100 issued and pending patents across more than 20 patent families.
“We founded RIVANNA to solve a problem that cuts across care settings: decision-critical information sits outside the point-of-care workflow,” said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. “BoneEnhance is where the stack begins to close that gap for musculoskeletal care: automated volumetric acquisition, now paired with cleared software-assisted review. This clearance is the foundation: the first machine learning layer, anchoring the decision-support capabilities now in development.”
Independently validated within a nationwide eight-site study
BoneEnhance was trained and validated within RIVANNA’s nationwide eight-site clinical study. Three sites contributed the training data; the other five provided the independent test set of 233 volumetric datasets, comprising 69,900 images from 173 subjects. None of the test data were used for training or tuning. Three board-certified radiologists established the reference labels, and per-volume label prediction accuracy, a measure of anatomical labeling, ranged from 95.1% to 100.0%.
Separate from the validation supporting this clearance, the platform’s automated acquisition carries peer-reviewed evidence: in a published study of 205 patients in the Journal of Emergency Medicine (DOI: 10.1016/j.jemermed.2025.11.011), operators with one hour of hands-on training acquired wrist and ankle images rated adequate for diagnostic interpretation in more than 90% of scans, with image quality comparable to physician-acquired scans.
“This clearance reflects the strength of the team RIVANNA has built across AI development, clinical affairs, and regulatory execution, and the commitment of the clinical sites that partnered with us to generate the evidence,” said Delphine Le Roux, PhD, PMP, Senior Director, Market Access and Strategic Partnerships at RIVANNA. “None of it happens without BARDA’s sustained support, which allowed us to do this the right way: rigorous, multi-site, and independent. The infrastructure, partnerships, and regulatory playbook we established for BoneEnhance are designed to carry forward. That execution engine is what positions us to pursue the next clearance with confidence.”
The next layer in development
The platform’s progression continues with an investigational musculoskeletal injury detection module. Where BoneEnhance labels the anatomy, the new module is being developed to assist clinicians in evaluating potential extremity fractures within acquired ultrasound images. The nationwide clinical study that trained and validated BoneEnhance, now expanded from eight to ten sites, is building the datasets used to train the module. Because the sites and data infrastructure were established once and are reused for each new module, every subsequent module builds on the program’s federal investment.
Federal funding acknowledgment
This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; the Administration for Strategic Preparedness and Response (ASPR); Biomedical Advanced Research and Development Authority (BARDA), under contract number 75A50121C00035.
About Accuro XV
Accuro XV is a portable, small-footprint point-of-care volumetric ultrasound imaging system for musculoskeletal imaging. Its conformable three-dimensional probe automates large field-of-view B-mode image acquisition without ionizing radiation. BoneEnhance is a cleared machine learning software module available during review of Accuro XV volumetric image acquisitions. It segments bone and surrounding tissues and supports visualization of skeletal anatomy in three dimensions.
An investigational computer-aided musculoskeletal injury detection module is in development for Accuro XV. It is designed to assist clinicians in detecting extremity fractures from volumetric ultrasound and annotating soft-tissue signs associated with injury, and to support triage decisions, including referral for additional radiographic imaging.
Accuro XV is designed to provide a fracture-care layer at the point of triage, helping to streamline emergency department workflows, expedite evaluation of low-severity extremity injuries, and reduce reliance on X-ray referrals. The platform is designed to support just-in-time training to promote consistent use across clinical experience levels, advancing a shared mission to transform musculoskeletal injury care while supporting broader emergency preparedness objectives.
About RIVANNA
RIVANNA is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company’s platform is designed to automate complex anatomical analysis at the point of care, support faster and more confident clinical decisions, reduce variability, and expand access to advanced capabilities. Its initial applications address interventional guidance and trauma triage, beginning with neuraxial procedures and musculoskeletal injury assessment. RIVANNA has established an FDA-cleared product portfolio and maintains a worldwide intellectual-property portfolio of more than 100 issued and pending patents. RIVANNA is headquartered in Charlottesville, Virginia, and operates an FDA-registered, ISO 13485:2016-certified manufacturing facility.
RIVANNA, Accuro, BoneEnhance, and the Rivanna Medical family of marks are registered and unregistered trademarks of Rivanna Medical, Inc. in the United States and other jurisdictions.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fda-grants-510k-clearance-for-boneenhance-the-first-machine-learning-layer-on-rivannas-accuro-xv-platform-302917179.html
SOURCE RIVANNA
Harlem Children’s Zone Acquires FinTech Platform, Goalsetter, to Accelerate Universal Economic Mobility
Common Ground in the Battlegrounds? Surveys Reveal Widespread Bipartisan Agreement in 11 Competitive States and 28 Congressional Districts, as Well as Nationally
FDA grants 510(k) clearance for BoneEnhance, the first machine learning layer on RIVANNA’s Accuro XV platform
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days agoBioethanol from human hair – Indian start-up’s solution to rising prices of grains and sugar
-
Technology4 days agoGMIF2026: AI Inference Powers the “Token Factory” and Drives System-Level Rethinking of Memory & Storage
-
Technology3 days agoInstaMall Launches Same-Day Fashion Delivery Experience, Bringing 80+ Brands to Shoppers’ Doors in Miami
-
Coin Market3 days agoWorld Liberty’s USD1 stablecoin sheds $400M in market cap in two weeks
-
Technology4 days agoTruecaller announces preliminary numbers for the third quarter 2026
-
Technology4 days agoSALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
-
Technology4 days agoLinktel Technologies Highlights Breakthrough 1.6T LPO Performance & Strong Market Pull at OCP 2026
-
Technology4 days agoTrend Micro Announces Up to ¥10 Billion toward Cyber Resilience Initiative to Strengthen Security for Japanese Organizations in the AI Era
